Lupin 2023

Issue 09-24-2012

Advertising falls short when Rxs switch to O-T-C

Apparently, there’s a key change in advertising when a prescription drug goes over the counter. Although a prescription drug’s risk-and-benefit profile doesn’t change in moving to O-T-C status, consumer advertisements for the O-T-Cs contain much less information about the drugs’ potential risks than the ads for when the medicines were prescription-only, a CVS Caremark-sponsored study